.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Teva
Farmers Insurance
Fish and Richardson
Accenture
Moodys
QuintilesIMS
Federal Trade Commission
Boehringer Ingelheim
Baxter

Generated: September 21, 2017

DrugPatentWatch Database Preview

ADRENALIN Drug Profile

« Back to Dashboard

Which patents cover Adrenalin, and when can generic versions of Adrenalin launch?

Adrenalin is a drug marketed by Par Sterile Products and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has one patent family member in one country.

The generic ingredient in ADRENALIN is epinephrine. There are nineteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

Summary for Tradename: ADRENALIN

Patents:2
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list63
Clinical Trials: see list26
Patent Applications: see list7,558
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ADRENALIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
ADRENALIN
epinephrine
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS204200-001Dec 7, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
Par Sterile Products
ADRENALIN
epinephrine
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS204640-001Dec 18, 2013RXYesYes► Subscribe► Subscribe ► Subscribe
Par Sterile Products
ADRENALIN
epinephrine
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS204200-001Dec 7, 2012RXYesYes► Subscribe► Subscribe ► Subscribe
Par Sterile Products
ADRENALIN
epinephrine
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS204640-001Dec 18, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ADRENALIN

Drugname Dosage Strength RLD Submissiondate
epinephrineInjection1 mg/mL ampulesAdrenalin3/9/2016

International Patent Family for Tradename: ADRENALIN

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2016149028► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Cipla
Daiichi Sankyo
Federal Trade Commission
Moodys
Queensland Health
McKinsey
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot